IMMUNOGEN INC's ticker is IMGN and the CUSIP is 45253H101. A total of 3 filers reported holding IMMUNOGEN INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,235,226 | -2.4% | 140,846 | +16.0% | 0.00% | 0.0% |
| Q2 2023 | $2,291,328 | +2279.8% | 121,427 | +384.3% | 0.00% | – |
| Q1 2023 | $96,284 | -21.7% | 25,074 | +1.1% | 0.00% | – |
| Q4 2022 | $123,003 | +3.4% | 24,799 | -0.0% | 0.00% | – |
| Q3 2022 | $119,000 | -8.5% | 24,810 | -13.9% | 0.00% | – |
| Q2 2022 | $130,000 | -8.5% | 28,812 | -1.7% | 0.00% | – |
| Q1 2022 | $142,000 | -34.0% | 29,319 | +1.2% | 0.00% | – |
| Q4 2021 | $215,000 | +34.4% | 28,985 | +2.7% | 0.00% | – |
| Q3 2021 | $160,000 | -12.6% | 28,235 | +1.8% | 0.00% | – |
| Q2 2021 | $183,000 | -25.0% | 27,725 | -8.1% | 0.00% | – |
| Q1 2021 | $244,000 | +29.8% | 30,171 | +3.3% | 0.00% | – |
| Q4 2020 | $188,000 | +102.2% | 29,216 | +13.2% | 0.00% | – |
| Q3 2020 | $93,000 | -25.6% | 25,805 | -5.4% | 0.00% | – |
| Q2 2020 | $125,000 | -35.6% | 27,272 | -51.9% | 0.00% | – |
| Q1 2020 | $194,000 | +5.4% | 56,736 | +57.0% | 0.00% | – |
| Q4 2019 | $184,000 | +201.6% | 36,129 | +44.3% | 0.00% | – |
| Q3 2019 | $61,000 | – | 25,037 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SILVERARC CAPITAL MANAGEMENT, LLC | 600,000 | $3,870,000 | 2.25% |
| CM Management, LLC | 375,000 | $2,419,000 | 2.24% |
| Consonance Capital Management LP | 3,515,944 | $22,678,000 | 2.12% |
| RA Capital Management | 18,417,458 | $118,793,000 | 1.66% |
| Kercheville Advisors, LLC | 244,421 | $1,564,000 | 0.85% |
| Redmile Group, LLC | 10,528,179 | $67,907,000 | 0.82% |
| Birchview Capital, LP | 190,000 | $1,226,000 | 0.71% |
| QVT Financial LP | 1,375,900 | $8,875,000 | 0.49% |
| Fernwood Investment Management, LLC | 149,340 | $963,000 | 0.38% |
| TWIN FOCUS CAPITAL PARTNERS, LLC | 104,068 | $671,000 | 0.21% |